IP Pharma
IP Pharma is a UK-based professional advisory firm that provides M&A and portfolio advisory services to pharmaceutical, biotechnology, medical device, and healthcare service companies, specializing in confidential acquisition and divestment search, deal structuring, and due diligence across the pharma product life cycle.
- Company typePrivate
- Founded2008
- HeadquartersLeeds, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What IP Pharma does
IP Pharma (IPP) is a Leeds, United Kingdom-based professional advisory firm founded in 2008 that provides transaction and portfolio advisory services to pharmaceutical, biotechnology, medical device, and healthcare service companies. The firm specializes in confidential search and tailored advice for organizations seeking to acquire or divest pharmaceutical assets across the full product life cycle, from pre-marketed candidates through Rx, Gx, and OTC/CHC licensed medicines, and claims advisory involvement on transactions representing over $7.0bn of cumulative client deal value. Its buyer-side practice works with pharma acquirers of all sizes, and its seller-side practice matches products marked for divestment with potential acquirers using up-to-date market information.
The firm's service line is organized around seven core offerings delivered as consultative engagements rather than as packaged products or platforms: Deal Development (asset valuation and deal structuring), Management Building (stand-up of experienced teams for newcos backed by PE, hedge funds, or investment banks), Advisory (end-to-end deal negotiation support), Outsourced Business Development (short- or long-term BD delivery across asset types and therapy areas), Due Diligence (financial, commercial, manufacturing and supply, legal, marketing, regulatory, and pharmacovigilance workstreams), Acquirer Services (confidential search across the product life cycle), and Divestment Services (matching sell-side products to buyer requirements). There is no proprietary software platform, AI system, or integrated technology stack disclosed; the firm's competitive substance is its advisor expertise and proprietary visibility into mandates and asset availability.
IP Pharma makes money through professional advisory fees on a per-engagement basis, with no publicly disclosed pricing or contract terms. It runs a sales-led, relationship-driven go-to-market targeting enterprise clients including big pharma, midcaps, biotech start-ups, medical device companies, healthcare service firms, private equity, venture capital, and investment banks, and positions itself as serving clients globally despite a single UK office. The firm is privately held with no disclosed funding rounds, parent company, ownership changes, or institutional investors, and is operationally anchored on Director Dr. Burrinder Grewal.
IP Pharma firmographics
Firmographics- Name
- IP Pharma
- Legal name
- IP Pharma
- Website
- https://ippharma.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- IP Pharma is a UK-based professional advisory firm that provides M&A and portfolio advisory services to pharmaceutical, biotechnology, medical device, and healthcare service companies, specializing in confidential acquisition and divestment search, deal structuring, and due diligence across the pharma product life cycle.
- Ownership category
- akta.pro rank
IP Pharma industry classification
Industry- Product category
- Pharmaceutical M&A Advisory
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211)
- akta.pro primary industry
- IPO & Public Markets Advisory (BPAHADAH)
Keywords
Where IP Pharma is headquartered
LocationHeadquarters
- HQ city
- Leeds
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
IP Pharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Advisory Services: Professional advisory services for acquisition and divestment of pharmaceutical assets, including deal development, management building, and due diligence services. Revenue is generated through advisory fees for services rendered to clients including pharma companies, PE funds, and investment banks.
Go-to-market motion1 record
Distribution channels1 record
IP Pharma product offering
Product offeringCore offering
IP Pharma is a professional advisory firm that provides confidential search, asset valuation, and transaction support services to pharmaceutical, biotechnology, medical device, and healthcare service companies. The firm specializes in matching buyers and sellers of pharmaceutical assets across the full product lifecycle, from pre-marketed candidates through Rx, Gx, and OTC/CHC licensed medicines, and offers deal development, management building, due diligence, and outsourced business development services.
Product overview
IP Pharma offers professional advisory services to Pharmaceutical, Biotechnology, Medical Device, and Healthcare Service companies as a single, unified service offering. The company specializes in searching for and valuing products for acquisition or divestment and bringing buyers and sellers together. The services include Deal Development, Management Building, Advisory, Outsourced Business Development, Due Diligence, Acquirer Services, and Divestment Services—all delivered as consultative professional advisory engagements rather than software products or platforms.
Differentiator
Problem solved
Functional benefit
Products and services
- Deal Development Services
- Management Building Services
- Advisory Services
- Outsourced Business Development
- Due Diligence Services
- Acquirer Services
- Divestment Services
Quantifiable outcome
- Advisory expertise representing over $7.0bn of value
Companies that use IP Pharma
Customer profileSegments4 records
Ideal customer profiles3 records
IP Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
IP Pharma partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights3 records
IP Pharma competitors and assessment
Company assessmentBroad incumbents
- Houlihan Lokey: Global investment bank with active healthcare and life sciences M&A practice, including pharma divestitures and BD support — overlapping capability set at broader scale.
- Jefferies Healthcare Group: Global investment bank with a dedicated healthcare M&A and equity capital markets franchise — broader incumbent serving pharma clients with overlapping transaction advisory capabilities.
- Greenhill & Co. M&A advisory firm with significant healthcare and pharma deal practice, providing strategic and corporate finance advisory at a larger scale than IP Pharma.
Direct peers
- Catenion: Specialist consulting firm focused on pharma and biotech strategy, R&D portfolio management, and transaction support — comparable boutique advisory with domain depth.
- Locust Walk: Life sciences-focused M&A and strategic advisory firm offering deal sourcing, due diligence, and transaction support — overlapping services and buyer/seller matching role for biotech and pharma clients.
- PharmaVentures: UK-based pharma transaction advisory firm supporting licensing, M&A, and divestments across all stages of the product lifecycle; directly comparable in service offering, geography, and client base (big pharma, midcaps, PE).
- Torreya (now part of Stout): Pharmaceutical M&A advisory firm (now within Stout) advising on pharma and biotech transactions, valuations, and divestments — directly comparable service set and target clients.
- Clarion Healthcare: Specialist pharma and life sciences strategy consulting firm advising on BD, deal support, and product commercialization for similar pharma/biotech clients.
- Deallus Consulting: Pharma and life sciences strategy consultancy offering commercial due diligence and BD advisory comparable to IP Pharma's advisory and outsourced BD offerings.
- Alantra Pharma & Biotech: Independent financial advisor with a dedicated pharma and biotech practice covering M&A, licensing, and capital markets advisory to pharma companies and investors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
IP Pharma social profiles
Digital presenceIP Pharma compliance and trust
Trust signalCompliance1 record
IP Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
IP Pharma leadership team
Management profileNumber of profiles
Profiles1 record
IP Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IP Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IP Pharma
What does IP Pharma do?
IP Pharma is a professional advisory firm that provides confidential search, asset valuation, and transaction support services to pharmaceutical, biotechnology, medical device, and healthcare service companies. The firm specializes in matching buyers and sellers of pharmaceutical assets across the full product lifecycle, from pre-marketed candidates through Rx, Gx, and OTC/CHC licensed medicines, and offers deal development, management building, due diligence, and outsourced business development services.
Is IP Pharma a public or private company?
IP Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was IP Pharma founded?
IP Pharma was founded in 2008. It employs 11 to 50 people.
Where is IP Pharma based?
IP Pharma is headquartered in Leeds, United Kingdom, in the Europe region.
How does IP Pharma make money?
One revenue line is on record: advisory Services.
Who are IP Pharma's main competitors?
Broad incumbents on record are Houlihan Lokey, Jefferies Healthcare Group and Greenhill & Co.. Direct peers are Catenion, Locust Walk, PharmaVentures, Torreya (now part of Stout), Clarion Healthcare, Deallus Consulting and Alantra Pharma & Biotech.
Does IP Pharma have an API?
No public API is recorded for IP Pharma.
What industry is IP Pharma in?
IP Pharma's product category is Pharmaceutical M&A Advisory. Its primary akta.pro industry code is BPAHADAH, IPO & Public Markets Advisory. Its NAICS code is 523940 and its SIC code is 6211.